Updated Global TB Vaccine Pipeline available

The Stop TB Partnership Working Group on New TB Vaccines presents the Tuberculosis Vaccine Candidates 2011, as an update of the 2009 Pipeline.

Read More →

Tuberculosis is a women's issue too

On March 8, and across the world the International Women's Day is being commemorated. Coincidentally, March is the global tuberculosis (TB) awareness month. The disease, which is caused by a mycrobatrium, has a major impact on women's sexual reproductive health and that of their children.

Read More →

South Africa: Preventative TB trial disappoints

After seven years of research, the world's largest study of preventative tuberculosis (TB) therapy has found that untargeted, community-wide distribution of TB prevention drugs did not improve TB control on South African gold mines.

Read More →

Indian TB cases highlight need for drug-resistance tests

A renewed call for cheap tests that can rapidly identify resistant forms of the disease.

Read More →

South Africa: Health Barometer shows slight progress

According to the District Health Barometer, TB and HIV are still the main causes of death. But the Barometer reveals that some districts have shown great improvements in tackling these diseases.

Read More →

More than 900 000 lives saved by protecting people living with HIV from TB

Updated WHO guidance launched today scales up effective public health interventions to reduce TB deaths for people living with HIV.

Read More →

A court case and a mathematical model expose the risk of TB in South African prisons

Dudley Lee's case reveals how overcrowding and a struggling court system are fuelling a TB epidemic.

Read More →

Strong advocacy needed to eliminate TB as a major killer of children

A new paper outlining the pressing need for more advocacy efforts to address childhood TB has been published in the European Respiratory Journal.

Read More →

European Medicines Agency recommends first-line anti-TB drugs for children

The European Medicines Agency (EMA)'s Committee for Medicinal Products for Human Use (CHMP) agrees with the World Health Organization (WHO) dosing recommendations for ethambutol, isoniazid, pyrazinamide, and rifampicin as first-line antituberculosis medicines used in children, according to new EMA dosing guidelines released February 17.

Read More →

Review: Tuberculosis and HIV co-infection

TB/HIV co-infection represents a novel pathogenic scenario at the global level. Our knowledge about the mechanisms of interaction of the two pathogens still has many gaps that need to be filled in order to develop preventive measures against the two diseases.

Read More →

Page 78 of 83 · Total posts: 10

←First 77 78 79 Last→